More effective therapies are needed for acute leukemia, particularly for people over 50 years of age at diagnosis, according to research published today by the Medical Journal of Australia.
Mar 14, 2022
0
2
Ruth M. Risueño leads the Leukaemic Stem Cell group of the Josep Carreras Leukaemia Research Institute. This group investigates Acute Myeloid Leukaemia (AML) and the cell population responsible for the disease spreading, ...
Sep 6, 2019
0
6
In a world first, Newcastle researchers have discovered the mechanisms acute myeloid leukemia (AML) cells use to produce "free radicals"—the byproduct of a cell process that aggressively fuels the growth of cancer cells ...
Mar 29, 2023
0
46
(Medical Xpress) -- A trial of a new drug for patients with hereditary breast or ovarian cancer at an advanced stage has been launched at the University of Oxford.
Aug 17, 2011
0
0
Selecting better matched recipients and donors than is currently required for umbilical-cord blood transplantation could substantially reduce transplant-related deaths. The findings, published Online First in the Lancet Oncology ...
Oct 6, 2011
0
0
Telethon Kids Institute (TKI) researchers have discovered a new drug combination to help babies battle a rare, aggressive type of leukaemia with grim cure rates.
Oct 12, 2016
0
0
Adelaide scientists have devised a way to enhance the effectiveness of a patient's leukaemia treatment by using a combination of drugs.
Mar 8, 2018
0
1
Children affected by trisomy 21 (or Down syndrome) are 50 to 500 times more likely to develop leukemia than other children.
Aug 8, 2014
0
0
The report, 'Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates' by colleagues at Melbourne and Adelaide universities, has passed peer review on F1000Research.
Nov 25, 2015
0
3
New research led by UCL and Great Ormond Street Hospital (GOSH) to predict which childhood leukemia patients are at higher risk of not responding well to chemotherapy could allow clinicians to refine treatment strategies ...
May 5, 2023
0
6
